Moreover, blocking Shh signaling [154], increasing the amount of RhoA-GTP, inhibiting the interaction between RhoA and Rho-GDI [155], inducing the activation of AMPK and p38 MAPK [155] are suggested to be implicated in anti-cancer effects of simvastatin. This evidence concerns the gene RHOA and cancer.